Other authors have published that mPGES-1, a therapeutic target downstream of COX enzymes, protects from cardiac ischemia/reperfusion injury, limiting leukocyte–endothelial interactions and preserving microvascular perfusion partly via the endothelial EP4 receptor [38]. The gene discussed is PTGES; the disease is myocardial ischemia.